Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Conmed (CNMD) EBT (2016 - 2026)

Conmed filings provide 17 years of EBT readings, the most recent being $18.4 million for Q1 2026.

  • On a quarterly basis, EBT rose 139.25% to $18.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $81.8 million, a 43.7% decrease, with the full-year FY2025 number at $71.1 million, down 56.38% from a year prior.
  • EBT hit $18.4 million in Q1 2026 for Conmed, down from $29.3 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $56.5 million in Q3 2024 to a low of -$93.5 million in Q2 2022.
  • Median EBT over the past 5 years was $18.4 million (2026), compared with a mean of $15.4 million.
  • Biggest five-year swings in EBT: plummeted 673.96% in 2022 and later skyrocketed 940.06% in 2024.
  • Conmed's EBT stood at -$10.5 million in 2022, then soared by 486.06% to $40.7 million in 2023, then rose by 7.27% to $43.6 million in 2024, then tumbled by 32.97% to $29.3 million in 2025, then crashed by 37.25% to $18.4 million in 2026.
  • The last three reported values for EBT were $18.4 million (Q1 2026), $29.3 million (Q4 2025), and $4.3 million (Q3 2025) per Business Quant data.